Thyrocare Technologies Ltd

NSE: THYROCARE · BSE: 539871 · Healthcare · 41 announcements

Share price: ₹513.40
Market cap: ₹8,172 Cr
Revenue (annual): ₹829.0 Cr
Net profit (annual): ₹163.0 Cr
P/E (TTM): 46.4×Sector 53.1×
Promoter holding: 60.92%+0.00% QoQ
FII holding: 5.43%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Share Pledge 4 Merger & Restructuring 2 Promoter Selling 1 Promoter Buying (Off-Market) 1 Employee Stock Options 1 Debt & Borrowing 1 Capital Structure Change 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

21 Sep 2026 14:57 IST BSE

Merger & Restructuring

Thyrocare Technologies Merger & Restructuring Worth ₹141.4 Cr

Thyrocare's board approved sale of 100% in Nueclear Healthcare to Trovera for ~₹141.40 Crore. The move exits radiology to refocus on core pathology business.

Value: ₹141.4 Cr
Execution: On or before November 30, 2026

Read the filing ↗

1 Sep 2026 17:21 IST BSE

Merger & Restructuring

Thyrocare Technologies Merger & Restructuring

NCLT sanctioned the merger of Docon Technologies into API Holdings. Accordingly, the promoter's 51.02% stake in Thyrocare transfers to API Holdings, leaving the aggregate shareholding unchanged.

Read the filing ↗